Dr. Gregory S. Van Dyke, MD, PhD

Dr. Van Dyke practices at Pacific Dermatopathology in Studio City, California.

Dr. Van Dyke's NPI, 1841328614, was assigned on March 1, 2007. Dr. Van Dyke graduated from UT Southwestern Medical Center in 2001. Dr. Van Dyke holds California license A81049.

Dr. Van Dyke's primary practice is Pacific Dermatopathology, at 12409 Ventura Ct Suite C Suite C, Studio City, CA 91604-2494. The practice phone is (818) 900-6007.

Dr. Van Dyke's primary practice is Pacific Dermatopathology in Studio City, California. The medical group on file is Pacific Dermatopathology. Dmand AI also links Dr. Van Dyke to 1 more group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Dyke practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Van Dyke's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Van Dyke is board certified in dermatology by the American Board of Dermatology. Dr. Van Dyke is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, joint cyst, scalp rash and skin cyst among the conditions Dr. Van Dyke treats.

CMS data shows 13,197 Medicare services from Dr. Van Dyke across 15 procedure codes in 2024, for 5,893 Medicare patients. Medicare paid $664,724 for them. Every service was in an office.

CMS counts 5,893 Medicare patients who saw Dr. Van Dyke in 2024. The largest group is 65 to 74, with 2,454 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Dyke's median patient age at 74, with 48% women.

In 2024, Dr. Van Dyke wrote 74 Medicare Part D claims for 25 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $291 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Van Dyke for performance year 2024, reported individually. Dr. Van Dyke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 176 procedures of removal of skin lesions by Dr. Van Dyke, more than 78% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Van Dyke in 2009. Dr. Van Dyke's most frequent co-authors are Navid Ezra, MD and Delphine Juihoa Lee, MD, PhD.

CMS Open Payments shows 486 general payments to Dr. Van Dyke from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,244.

Dr. Van Dyke graduated from UT Southwestern Medical Center in 2001.

Dr. Van Dyke is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.